GlassScriptPhysician profile
Erin Roberts
NPI 1699310367
$1,086.29
in general payments reported to CMS, 2019-2025
13 companies · $252 in 2025
The $252 reported for 2025 was more than what 81% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.20 · 2022: $108 · 2023: $347 · 2024: $353 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $952.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $332.81 | 2023-2024 | Jornay Pm |
| Corium, LLC | $191.19 | 2023-2025 | Azstarys |
| Sanofi Pasteur INC. | $145.26 | 2023-2025 | |
| Cranial Technologies, INC | $97.44 | 2023-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $84.50 | 2021-2023 | Vaxneuvance, Gardasil 9, Vaxelis |
| Medline Industries LP | $67.10 | 2022 | |
| Verrica Pharmaceuticals INC. | $41.74 | 2023-2024 | Ycanth |
| Seqirus USA INC | $35.25 | 2023-2025 | Flucelvax Quadrivalent, Flucelvax |
| Pfizer INC. | $24.46 | 2023 | |
| Pharmacosmos Therapeutics INC. | $23.95 | 2025 | Monoferric |
| Ars Pharmaceuticals Operations, INC. | $16.86 | 2025 | Neffy |
| Kowa Pharmaceuticals America, INC. | $13.14 | 2024 | Zoryve |
| Qiagen, LLC | $12.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.